Products - Acute coronary syndromes | Topic | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Showing 68 products

Date | Title

Intravascular lithotripsy to treat calcified coronary arteries during percutaneous coronary intervention (IPG802)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
5 February 2025
Temperature control to improve neurological outcomes after cardiac arrest (IPG782)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
23 January 2024
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)
Product type:
Guidance
Programme:
NICE guideline
Published:
14 December 2023
CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessment (HTE4)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
9 March 2023
Bioresorbable stent implantation to treat coronary artery disease (IPG732)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
3 August 2022
Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides (TA805)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
13 July 2022
MiraQ for assessing graft flow during coronary artery bypass graft surgery (MTG8)
Product type:
Guidance
Programme:
Medical technologies guidance
Last updated:
5 July 2022
Published:
16 November 2011
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (MTG32)
Product type:
Guidance
Programme:
Medical technologies guidance
Last updated:
19 May 2021
Published:
13 February 2017
QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography (DG43)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
17 March 2021
Acute coronary syndromes (NG185)
Product type:
Guidance
Programme:
NICE guideline
Published:
18 November 2020
Drug-eluting stents for the treatment of coronary artery disease (TA152)
Product type:
Guidance
Programme:
Technology appraisal guidance
Last updated:
18 November 2020
Published:
23 July 2008
Guidance on the use of coronary artery stents (TA71)
Product type:
Guidance
Programme:
Technology appraisal guidance
Last updated:
18 November 2020
Published:
22 October 2003
High-sensitivity troponin tests for the early rule out of NSTEMI (DG40)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
26 August 2020
Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease (TA607)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
17 October 2019
Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions (IPG633)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
28 November 2018
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners (DG3)
Product type:
Guidance
Programme:
Diagnostics guidance
Last updated:
6 July 2017
Published:
25 January 2012
Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
14 December 2016
Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis (CG95)
Product type:
Guidance
Programme:
Clinical guideline
Last updated:
30 November 2016
Published:
24 March 2010
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal) (TA351)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
22 July 2015
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome (TA335)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
25 March 2015
Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes (TA317)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
23 July 2014
Endoscopic saphenous vein harvest for coronary artery bypass grafting (IPG494)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
25 June 2014
Optical coherence tomography to guide percutaneous coronary intervention (IPG481)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
23 February 2014
Ticagrelor for the treatment of acute coronary syndromes (TA236)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
26 October 2011
Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction (TA73)
Product type:
Guidance
Programme:
Technology appraisal guidance
Last updated:
1 July 2011
Published:
26 November 2003
Percutaneous laser coronary angioplasty (IPG378)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
26 January 2011
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (TA210)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
15 December 2010
Cardiovascular disease prevention (PH25)
Product type:
Guidance
Programme:
Public health guideline
Published:
22 June 2010
Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes (TA47)
Product type:
Guidance
Programme:
Technology appraisal guidance
Last updated:
1 March 2010
Published:
5 September 2002
Percutaneous laser revascularisation for refractory angina pectoris (IPG302)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 May 2009
Transmyocardial laser revascularisation for refractory angina pectoris (IPG301)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 May 2009
Cardiovascular disease: identifying and supporting people most at risk of dying early (PH15)
Product type:
Guidance
Programme:
Public health guideline
Published:
24 September 2008
Endoaortic balloon occlusion for cardiac surgery (IPG261)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
28 May 2008
Totally endoscopic robotically assisted coronary artery bypass grafting (IPG128)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
22 June 2005
Intraoperative fluorescence angiography for the evaluation of coronary artery bypass graft patency (IPG98)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 October 2004
Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction (TA52)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
30 October 2002
MiraQ cardiac TTFM with high-frequency probe for assessing graft flow during coronary artery bypass graft surgery (MIB323)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
20 June 2023
Spartan RX point-of-care CYP2C19 test to guide treatment in acute coronary syndrome (MIB223)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
11 August 2020
Optowire for measuring fractional flow reserve (MIB199)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
3 December 2019
DuraGraft for preserving vascular grafts (MIB184)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
8 May 2019
Kendall DL for ECG monitoring in people having cardiac surgery (MIB177)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
18 March 2019
VEST external stent for coronary artery bypass grafts (MIB115)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
2 August 2017
Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult (MIB53)
Product type:
Advice
Programme:
Medtech innovation briefing
Last updated:
6 July 2017
Published:
1 March 2016
Somatom Definition Edge CT scanner for imaging coronary artery disease in adults in whom imaging is difficult (MIB54)
Product type:
Advice
Programme:
Medtech innovation briefing
Last updated:
6 July 2017
Published:
1 March 2016
Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions (MIB89)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
29 November 2016
Coronary revascularisation: Cangrelor (ESNM63)
Product type:
Advice
Programme:
Evidence summary
Published:
3 November 2015
Thermogard XP for therapeutic hypothermia after cardiac arrest (MIB37)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
9 September 2015
The PressureWire fractional flow reserve measurement system for coronary artery disease (MIB2)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
4 February 2014
The RhinoChill intranasal cooling system for reducing temperature after cardiac arrest (MIB4)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
1 February 2014
Cardiovascular risk assessment and lipid modification (QS100)
Product type:
Quality standard
Last updated:
24 May 2023
Published:
4 September 2015
Acute coronary syndromes in adults (QS68)
Product type:
Quality standard
Last updated:
18 November 2020
Published:
5 September 2014
Secondary prevention after a myocardial infarction (QS99)
Product type:
Quality standard
Published:
4 September 2015
Drug-eluting coronary stents for treating coronary artery disease: late-stage assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
6 May 2025
Cardiovascular risk assessment and lipid modification
Status:
In development
Expected publication date:
23 July 2025
Venoarterial Extracorporeal membrane oxygenation (VA ECMO) for extracorporeal cardiopulmonary resuscitation (ECPR) in adults in refractory cardiac arrest
Status:
In development | In consultation
Programme:
Interventional procedures guidance
Consultation end date:
21 May 2025
Expected publication date:
11 September 2025
Digital platforms to support cardiac rehabilitation: early value assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
18 November 2025
Insertion of a Catheter based intravascular microaxial blood pump for acute heart failure
Status:
Awaiting development
Programme:
Interventional procedures guidance
Expected publication date:
11 March 2026
Empagliflozin for preventing cardiovascular events after acute myocardial infarction [ID6240]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Coronary venous arterialisation in patients with refractory angina
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Optical Coherence Tomography to guide percutaneous coronary intervention
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke TS ID 11920
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Semaglutide for managing overweight and obesity and the reduction of associated cardiovascular risk (ID6441 including a review of TA875 and TA910)
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Spartan RX point-of-care CYP2C19 test
Status:
Topic selection
Programme:
Diagnostics guidance
Expected publication date:
TBC
Zoll ThermoGuard XP for Intravascular Temperature Management
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions
Status:
Awaiting development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions
Status:
Awaiting development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Multi-vessel minimal access coronary artery surgery for multi-vessel coronary artery disease
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Pelacarsen for reducing the risk of cardiovascular events in people with established cardiovascular disease and hyperlipidaemia [ID6559]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC